Postoperative Dialysis in Fontan Patients Undergoing Heart Transplant: How Predictive is the Pretransplant Serum

Humera Ahmed1, John Dykes2, Joshua Friedland-Little3

  • 1Division of Cardiology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.

PubMed

Insights

Fontan patients needing heart transplant (HT) have a higher risk of dialysis post-transplant, even with seemingly normal kidney function. Pre-transplant creatinine is an unreliable indicator of future dialysis needs in these patients.

Area of Science:

  • Pediatric Cardiology
  • Transplant Surgery
  • Nephrology

Background:

  • Fontan patients undergoing heart transplant (HT) often require hemodialysis (HD) post-transplant, despite seemingly preserved renal function.
  • This increased need for dialysis in Fontan patients post-HT has not been formally studied.

Purpose of the Study:

  • To investigate the incidence of post-heart transplant dialysis in children with Fontan circulatory failure (FCF) compared to those with cardiomyopathy (CM).
  • To identify factors associated with the need for post-transplant dialysis in FCF patients.

Main Methods:

  • Utilized the Pediatric Heart Transplant Society (PHTS) database (2005-2019) to identify children (≥2 years) undergoing isolated HT.
  • Defined primary endpoint as need for dialysis within 30 days post-HT; secondary outcome was 30-day mortality.
  • Calculated pre-transplant estimated glomerular filtration rate (eGFR) using the modified Schwartz formula.

Main Results:

  • 1994 children met criteria; 13% had FCF, 87% had CM. FCF patients were smaller than CM patients.
  • FCF patients showed a 4.8-fold higher incidence of post-transplant dialysis (3.8% vs. 0.8%, p<0.001) compared to CM patients.
  • Pre-transplant ECMO and longer cardiopulmonary bypass times were associated with post-transplant dialysis in FCF patients.

Conclusions:

  • Serum creatinine is a poor predictor of renal replacement therapy needs post-HT in FCF patients.
  • The modified Schwartz formula may overestimate renal function in Fontan patients.
Abstract